The intersection of radiopharmaceuticals and nanotechnology has propelled the field of medicine forward, particularly concerning targeted cancer therapies.

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...

A quarter of a century ago, Britain shared the accolade of having the worst survival rates for cancer patients in Western ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Discover how explainable AI (xAI) and real-world data (RWD) improve clinical decision-making in oncology by identifying key prognostic markers across multiple cancer types.

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

As cancer rates in the West, and globally, tack upwards due to lifestyle and environmental pollution, so does the need for ...

Many people at risk for lung cancer including current and former smokers undergo regular screening for lung cancer with a low ...

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast ...

Cranfield University's new sensor detects lung cancer biomarkers quickly, supporting precision medicine and improving early ...

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...